Gel4Med utilizes its proprietary Smart Materials Platform™ to develop biosynthetic matrices for wound care and surgical reconstruction. The company’s G4Derm™ and G4Derm™ Plus products specifically address the challenges of managing complex wounds, enhancing healing through a biomimetic approach.
Funding
$200K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Managing complex wounds and achieving successful surgical reconstruction pose significant challenges due to the limitations of existing materials in promoting effective tissue regeneration and minimizing complications. Current wound care solutions may lack the necessary biomimetic properties to fully support the natural healing process.
Solution
Gel4Med is a commercial-stage company that utilizes its proprietary Smart Materials Platform™ (SMP™) to develop bioinspired medical solutions. The company's G4Derm™ and G4Derm™ Plus products are biosynthetic matrices designed to address the challenges of wound care and surgical reconstruction. These flowable matrices leverage self-assembling peptides to create a biomimetic environment that supports tissue regeneration and enhances the healing process. The SMP™ technology offers a novel materials science approach to product development, with the potential to transform the wound care and surgical reconstruction industry.
Target Audience
The primary target audience includes healthcare providers specializing in wound care and surgical reconstruction, as well as hospitals and clinics seeking advanced biomaterial solutions.
Features
- Proprietary Smart Materials Platform™ (SMP™) for developing therapeutics and devices.
- G4Derm™ Plus: A flowable biomimetic matrix for managing complex wounds.
- Bioinspired design using self-assembling peptides.
- FDA 510(k) market clearance for G4Derm™ and G4Derm™ Plus.